nanobiotix

A new therapeutic modality in oncology

Surgery, radiotherapy, pharmaceutical and biological agents used alone or in combination are usual treatment modalities in oncology.

Distant dissemination but also local failure and relapses are the major causes for morbidity and mortality. Furthermore, given the biological complexity of cancer and the range of its clinical manifestations, it seems probable that an effective approach needs to address multiple biological targets. Nowadays, scientists are seeking physics-based solutions for controlling biological responses. In any case the key challenge to the development of any therapy that is aimed at controlling cancer is to ensure a significant cytotoxic effect on tumor cells that does not or minimally target normal tissue.

Medical specificities and needs could be adequately treated with different NanoXray nanoparticles which design and use are determined by the tumor type and size, the disease stage, the invasion profile, the anatomical site and the patient specificities. Thus, the pipeline of NanoXray offers the performance of personalized medicine based on the patient and tumor specificities including the cancer.

Physical attributes of nanoparticles such as shape, compartmentalization and mechanical properties are crucial to biological functions. Research is needed and the emergence of powerful innovative treatments, based on the design of organic and inorganic nanomaterials may bring more efficient eradication of cancer.